Bloomberg Biontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sanofi to Make Millions of BioNTech-Pfizer Vaccine Doses Bloomberg 1/27/2021 © Bloomberg BioNTech will give Sanofi access to its Frankfurt production facility. (Bloomberg) Sanofi agreed to produce millions of doses of BioNTech SE and Pfizer Inc.’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts. The French drugmaker will give BioNTech access to a production facility in Frankfurt, which will start to deliver doses this summer, Sanofi said in a statement Wednesday. The deal will produce more than 125 million doses of the messenger RNA vaccine for the European Union. Sanofi’s own effort to develop a Covid vaccine has stumbled, meaning it won’t be ready by summer as initially expected. The deal with BioNTech allows Europe to make up for some of the loss. The pact also raised hopes that more pharma giants would throw their manufacturing and distribution weight behind the few coronavirus shots that have proved effective.

France generalBloomberg biontechBloomberg sanofiOlivier bogillotGlaxosmithkline plcPfizer incEuropean unionLonza groupModerna incபிரான்ஸ் ஜநரல்ப்ளூம்பெர்க் சனோஃபிகிளாக்சோஸ்மித்க்லைன் ப்ல்ஃபைசர் இன்க்ஐரோப்பிய தொழிற்சங்கம்மாடர்னா இன்க்